Chronic obstructive pulmonary disease: Do regional differences in tissue inflammation matter?

Respiration

Volumn 81, Issue 5, 2011, Pages 359-361

  Van Eeden, Stephan F ^a   Hogg, James C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN G; CHEMOATTRACTANT; CHEMOKINE; CIGARETTE SMOKE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; HISTONE DEACETYLASE 2; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ELASTASE; MYELOBLASTIN; NEUTROPHIL COLLAGENASE; SERINE PROTEINASE; TRANSCRIPTION FACTOR RELA;

ADAPTIVE IMMUNITY; AIRWAY OBSTRUCTION; AIRWAY REMODELING; BRONCHUS BIOPSY; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; LEUKOCYTE; LUNG ALVEOLUS EPITHELIUM; LUNG EMPHYSEMA; LUNG ENDOTHELIUM; LUNG FIBROBLAST; LUNG INJURY; LUNG LAVAGE; LUNG TISSUE INFLAMMATION; MACROPHAGE; MUCUS SECRETION; NEUTROPHIL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SMALL AIRWAY OBSTRUCTION; SMOKING CESSATION; T LYMPHOCYTE SUBPOPULATION;

HUMANS; LUNG; MACROPHAGES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 79955104984     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323869     Document Type: Review

References (21)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
2. Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S; GOLD Scientific Committee: Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276. (Pubitemid 32378468)
3. Wright JL, Lawson LM, Pare PD, Kennedy S, Wiggs B, Hogg JC: The detection of smallairways disease. Am Rev Respir Dis 1984; 129: 989-994.
4. Hogg JC, Wright JL, Wiggs BR, Coxson HO, Opazo SA, Pare PD: Lung structure and function in cigarette smokers. Thorax 1994; 49: 473-478. (Pubitemid 24170400)
5. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD: Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164: 469-473. (Pubitemid 32778218)
6. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653. (Pubitemid 38787999)
7. Rutgers SR, Postma DS, Ten Hacken NHT, Kauffman HF, Van Der Mark TW: Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000; 55: 12-18. (Pubitemid 30248773)
8. Wright JL, Lawson LM, Pare PD, Wiggs BJ, Kennedy S, Hogg JC: Morphology of peripheral airways in current smokers and exsmokers. Am Rev Respir Dis 1983; 127: 474-477. (Pubitemid 13083749)
9. Tetley TD: Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 2005; 4: 607-618. (Pubitemid 41722371)
10. Isajevs S, Taivans I, Svirina D, Strazda G, Kopeika U: Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pul monary disease. Respiration 2011;81:362-371.
11. Floreani AA, Buchalter S, Thompson AB, Rennard SI: In vivo assessment of airway inflammation. Monaldi Arch Chest Dis 1994; 49(3 suppl 1):17-26. (Pubitemid 24244738)
12. Lams BE, Sousa AR, Rees PJ, Lee TH: Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 512-516. (Pubitemid 30158188)
13. Bosken CH, Hards J, Gatter K, Hogg JC: Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992; 145: 911-917.
14. Cosio MG, Guerassimov A: Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med 1999; 160:S21-S25.
15. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG: Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995; 152: 1666-1672. (Pubitemid 3002087)
16. Stanescu D, Sanna A, Veriter C, Kostianev S, Calcagni PG, Fabbri LM, Maestrelli P: Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51: 267-271. (Pubitemid 26086470)
17. Keatings VM, Barnes PJ: Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997;155: 449-453. (Pubitemid 27085784)
18. Smith SF, Guz A, Winning AJ, Cooke NT, Burton GH, Tetley TD: Comparison of human lung surface protein profiles from the central and peripheral airways sampled using two regional lavage techniques. Eur Respir J 1988; 1: 792-800.
19. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM: CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 822-826.
20. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK: Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155: 852-857. (Pubitemid 27133393)
21. Welsh RM, Che JW, Brehm MA, Selin LK: Heterologous immunity between viruses. Immunol Rev 2010; 235: 244-266.